Navigating the NASH Maze
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis research and in the search for new anti-fibrotic agents. Nowhere is this more evident than in the field of non-alcoholic steatohepatitis (NASH). While there have been multiple review articles covering NASH of late, TherapeutAix is […]
TherapeutAix to present at ELRIG’s flagship conference, Drug Discovery
The European Laboratory Research & Innovation Group’s (ELRIG) flagship conference, Drug Discovery, is one of the largest meetings of life sciences industry professionals in the UK. Now in its 12th year, Drug Discovery 2018 will take place in London’s Excel Arena. The 2-day event will bring together more than 1200 delegates and over 100 exhibiting […]